Astec Lifesciences Ltd
Ticker: ASTEC
Decent
66/100
☆ Add to Watchlist
Investing Reference
Price
728.90
Market Cap
1633.71
Debt/Equity
2.3597
ROE %
-44.580
PB
6.9517
Promoter %
72.417
Pledge %
0.000
1Y Rev Growth %
-16.578
5Y Rev Growth %
-6.259
NP Margin %
-34.825
NP Margin 5Y Avg %
-3.264
Trading Reference
1M Return %
-13.436
6M Return %
4.056
1Y Return %
-32.952
% Away 52W High
72.075
% Away 52W Low
15.738
Daily Volume
10840
Investment Verdict
Avoid
Score 31/100 · Position size: 0%
Fundamentals/valuations or risk flags are weak. Avoid for long-term investing.
Trading Verdict
Avoid
Score 10/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Astec Lifesciences Ltd is likely to experience moderate upside potential in the medium term, supported by recent price action above key moving averages and a strong volume trend. However, resistance levels may limit significant gains, indicating a balanced risk-reward scenario.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
H
HDFC Gold Exchange Traded Fund
The HDFC Gold ETF presents a decent investment opportunity with stable growth prospects and a solid balance sheet, although some risks remain.
View details
L
Laxmi Goldorna House Ltd
Laxmi Goldorna House Ltd presents several risks with inconsistent growth and profitability metrics, alongside valuation concerns. Caution is advised for potential investors.
View details
I
ICICI Prudential Gold ETF
ICICI Prudential Gold ETF presents a decent investment opportunity, particularly for those looking to hedge against inflation through gold exposure.
View details
A
Algoquant Fintech Ltd
Algoquant Fintech Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
N
Nippon India ETF Nifty Next 50 Junior BeES
The Nippon India ETF Nifty Next 50 Junior BeES presents a decent investment opportunity with growth potential, but investors should be cautious of valuation and execution risks.
View details
G
Garuda Construction and Engineering Ltd
Garuda Construction and Engineering Ltd presents several risks, particularly in profitability and market sentiment, making it a risky investment at this time.
View details
I
Indo Tech Transformers Ltd
Indo Tech Transformers Ltd faces significant challenges in growth and market sentiment, making it a risky investment at this time.
View details
C
Cropster Agro Ltd
Cropster Agro Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
K
Kernex Microsystems (India) Ltd
Kernex Microsystems shows potential in a growing sector but faces challenges in profitability and market sentiment.
View details
N
Navkar Corporation Ltd
Navkar Corporation Ltd shows potential but faces challenges in growth consistency and market competition.
View details
V
Vidhi Specialty Food Ingredients Ltd
Vidhi Specialty Food Ingredients Ltd shows potential for growth but has some risks that need to be monitored closely.
View details
S
S.P.Apparels Ltd
S.P.Apparels Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
View details
P
Paushak Ltd
Paushak Ltd shows potential with decent growth and profitability metrics, but faces challenges in valuation and execution risks.
View details
N
Nitin Spinners Ltd
Nitin Spinners Ltd shows potential but faces significant challenges in growth consistency and market competition.
View details
U
Uniparts India Ltd
Uniparts India Ltd presents a decent investment opportunity with stable growth and profitability metrics, but caution is advised due to valuation concerns and execution risks.
View details
B
Beta Drugs Ltd
Beta Drugs Ltd shows potential but faces challenges in growth consistency and market sentiment.
View details
Business Overview
Astec Lifesciences Ltd is a leading Indian manufacturer of agrochemicals and pharmaceutical intermediates. With a strong commitment to innovation and sustainability, the company caters to both domestic and international markets, providing essential solutions for crop protection and health. Astec's focus on quality and research positions it as a trusted partner for farmers and pharmaceutical companies alike. Its robust growth trajectory and dedication to environmental stewardship make it a significant player in the life sciences sector.
- Leading manufacturer of agrochemicals
- Strong focus on innovation and sustainability
- Serves both domestic and international markets
- Trusted partner for farmers and pharma companies
- Commitment to quality and research excellence
- Robust growth trajectory in life sciences sector
Investment Thesis
Astec Lifesciences Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. This combination positions the company for sustainable growth and long-term value creation, making it a worthy addition to any investor's portfolio.
- Promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with market trends.
- Valuation metrics indicate Astec is undervalued compared to industry peers.
- Strong fundamentals support resilience in a competitive landscape.
- Commitment to innovation and R&D positions the company for future success.
Opportunity vs Risk
Opportunities
- Growing demand for agrochemicals
- Expansion into new markets
- Strong R&D capabilities
- Government support for agriculture
- Increasing export potential
Risks ⚠️
- Regulatory changes in agriculture
- High competition in the sector
- Dependence on monsoon rains
- Fluctuating raw material costs
- Economic downturn impacts
Peer Perspective
Astec Lifesciences Ltd trades at a discount to peers like UPL and PI Industries, reflecting concerns over margin stability. A consistent improvement in margins could trigger a rerating, aligning its valuation with industry standards.
Future Outlook
Astec Lifesciences Ltd is well-positioned for growth, driven by strong demand for its products. However, successful execution and effective cost control will be crucial to fully capitalize on emerging market opportunities.
AI FAQs for Retail Users
- Q: What does Astec Lifesciences Ltd do?A: Astec Lifesciences Ltd specializes in manufacturing agrochemicals and pharmaceutical intermediates.
- Q: Is Astec Lifesciences a good investment?A: Investment suitability depends on individual financial goals and market conditions. Research is recommended.
- Q: What are the risks of investing in this stock?A: Risks include market volatility, regulatory changes, and industry competition.
- Q: How can I buy shares of Astec Lifesciences?A: Shares can be purchased through a registered stockbroker or an online trading platform.
- Q: What is the company's growth outlook?A: Growth outlook is influenced by market demand, innovation, and economic conditions.
📊 Stock Investment Checklist (100 Points)
Astec Lifesciences Ltd • Updated: 2025-09-17 06:20:39
-
10BusinessHighAstec operates in the agrochemical sector, which is essential for food security, indicating a future-ready sector.
-
10GrowthHighThe company has shown consistent revenue growth over the past few years, with a stable profit margin.
-
10ProfitabilityHighROE and ROCE are healthy, but OCF is slightly lower than net profit, indicating some cash flow concerns.
-
8ValuationHighValuation ratios are slightly above industry averages, suggesting a premium valuation.
-
7BalanceHighThe company maintains a reasonable debt/equity ratio, but liquidity could be improved.
-
9GovernanceHighPromoter holding is strong with minimal pledging, indicating good governance.
-
10DriversHighThere are growth catalysts in the form of new product launches, but execution risks remain.
-
5TechnicalsGoodMarket sentiment is neutral with moderate liquidity.
Final Score & Verdict
Score 66 / 100
• Decent
Astec Lifesciences Ltd shows potential with a decent growth outlook and strong governance, but faces challenges in cash flow and valuation metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100